A comparative study of atorvastatin and simvastatin as monotherapy for mixed hyperlipidaemia in Type 2 diabetic patients

Diabetes Research and Clinical Practice

Volumn 66, Issue 1, 2004, Pages 97-99

  Chan, W B ^a,b   Ko, G T C ^a,b   Yeung, V T F ^a,b   Osaki, R ^a,b   Ma, R C W ^a,b   So, W Y ^a,b   Chow, C C ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN; TRIACYLGLYCEROL;

ADULT; AGED; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HYPERLIPIDEMIA; LETTER; MAJOR CLINICAL STUDY; MEASUREMENT; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; FEMALE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTRIGLYCERIDEMIA; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; PYRROLES; SIMVASTATIN; TRIGLYCERIDES;

EID: 4444321275     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2004.06.007     Document Type: Letter

References (14)

1. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360 (9326) (2002) 7-22.
2. S.M. Haffner The Scandinavian Simvastatin Survival Study (4S) subgroup analysis of diabetic subjects: implications for the prevention of coronary heart disease Diabetes Care 20 4 1997 469 471
3. H.N. Ginsberg Lipoprotein physiology in nondiabetic and diabetic states Relationship to atherogenesis Diabetes Care 14 9 1991 839 855
4. D.B. Hunninghake, C.M. Ballantyne, D.L. Maccubbin, A.K. Shah, B. Gumbiner, and Y.B. Mitchel Comparative effects of simvastatin and atorvastatin in hypercholesterolemic patients with characteristics of metabolic syndrome Clin. Ther. 25 6 2003 1670 1686
5. A.G. Olsson, M. Eriksson, O. Johnson, T. Kjellstrom, J. Lanke, and M.L. Larsen A 52-week, multicenter, randomized, parallel-group, double-blind, double-dummy study to assess the efficacy of atorvastatin and simvastatin in reaching low-density lipoprotein cholesterol and triglyceride targets: the treat-to-target (3T) study Clin. Ther. 25 1 2003 119 138
6. C.C. Wu, R. Sy, V. Tanphaichitr, A.T. Hin, S. Suyono, and Y.T. Lee Comparing the efficacy and safety of atorvastatin and simvastatin in Asians with elevated low-density lipoprotein-cholesterol - a multinational, multicenter, double-blind study J. Formos. Med. Assoc. 101 7 2002 478 487
7. D.G. Karalis, A.M. Ross, R.M. Vacari, H. Zarren, and R. Scott Comparison of efficacy and safety of atorvastatin and simvastatin in patients with dyslipidemia with and without coronary heart disease Am. J. Cardiol. 89 6 2002 667 671
8. A. Branchi, A.M. Fiorenza, A. Torri, F. Muzio, C. Berra, and E. Colombo Effects of low doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol levels in patients with hypercholesterolemia Clin. Ther. 23 6 2001 851 857
9. J.R. Crouse III, J. Frohlich, L. Ose, M. Mercuri, and J.A. Tobert Effects of high doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I Am. J. Cardiol. 83 10 1999 1476 1477 A7
10. D.R. Illingworth, J.R. Crouse III, D.B. Hunninghake, M.H. Davidson, I.D. Escobar, and A.F. Stalenhoef A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial Curr. Med. Res. Opin. 17 1 2001 43 50
11. E.A. Stein, M. Lane, and P. Laskarzewski Comparison of statins in hypertriglyceridemia Am. J. Cardiol. 81 4A 1998 66B 69B
12. P.M. Ridker, N. Rifai, L. Rose, J.E. Buring, and N.R. Cook Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events New Engl. J. Med. 347 20 2002 1557 1565
13. R. Ross Atherosclerosis - an inflammatory disease New Engl. J. Med. 340 2 1999 115 126
14. O. Wiklund, L. Mattsson-Hulten, E. Hurt-Camejo, and J. Oscarsson Effects of simvastatin and atorvastatin on inflammation markers in plasma J. Intern. Med. 251 4 2002 338 347